Copyright
©The Author(s) 2018.
World J Clin Cases. Nov 6, 2018; 6(13): 600-610
Published online Nov 6, 2018. doi: 10.12998/wjcc.v6.i13.600
Published online Nov 6, 2018. doi: 10.12998/wjcc.v6.i13.600
Figure 4 Iron deposition in liver tissues with fibrosis of different stages.
Perls’ staining of iron appears as red granular particles in liver cells (× 400 magnification.) A-E: Different stages of liver fibrosis, respectively. Liver fibrosis was staged using the METAVIR scoring system, which consists of five stages: S0 (no fibrosis, n = 5), S1 (portal fibrosis without septa, n = 8), S2 (portal fibrosis with rare septa, n = 4), S3 (portal fibrosis with many septa, n = 7), and S4 (cirrhosis, n = 5). Markedly increased iron deposition was observed in the severe liver fibrosis (S3) and cirrhosis (S4) groups, but not in groups S0-S2. F: Significantly higher average iron retention (mean ± SEM) with severe fibrosis (S3: 23.7%) and cirrhosis (S4: 43.6%) compared to that with no or mild fibrosis (S0: 5.2%, S1: 7.9%; S2: 8.5%). A statistically significant difference in iron staining was observed among patients with severe fibrosis and cirrhosis (P < 0.05). aP < 0.05 vs S0; bP < 0.05 vs S1; cP < 0.05 vs S2; dP < 0.05 vs S3.
- Citation: Gao YH, Wang JY, Liu PY, Sun J, Wang XM, Wu RH, He XT, Tu ZK, Wang CG, Xu HQ, Niu JQ. Iron metabolism disorders in patients with hepatitis B-related liver diseases. World J Clin Cases 2018; 6(13): 600-610
- URL: https://www.wjgnet.com/2307-8960/full/v6/i13/600.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i13.600